SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040395
Filing Date
2019-11-05
Accepted
2019-11-05 16:16:37
Documents
55
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20190930.htm 10-Q 2004347
2 EX-10.1 kura-ex101_14.htm EX-10.1 34629
3 EX-10.2 kura-ex102_13.htm EX-10.2 11935
4 EX-10.3 kura-ex103_11.htm EX-10.3 79831
5 EX-31.1 kura-ex311_6.htm EX-31.1 17451
6 EX-31.2 kura-ex312_8.htm EX-31.2 17261
7 EX-32.1 kura-ex321_7.htm EX-32.1 9557
  Complete submission text file 0001564590-19-040395.txt   5661596

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT kura-20190930.xml EX-101.INS 1138899
9 XBRL TAXONOMY EXTENSION SCHEMA kura-20190930.xsd EX-101.SCH 39511
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20190930_cal.xml EX-101.CAL 39266
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20190930_def.xml EX-101.DEF 94644
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20190930_lab.xml EX-101.LAB 262927
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20190930_pre.xml EX-101.PRE 199484
Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 191193494
SIC: 2834 Pharmaceutical Preparations